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Serum-opsonized group A streptococcal cell walls, consisting of peptidoglycan-polysaccharide polymers
(PG-APS), induced monolayers of human neutrophils, monocytes, and eosinophils to aggregate. When
erythrocytes were present in the incubation medium, they also were associated with the leukocyte aggregates.
By immunofluorescence staining, PG-APS was localized at the site of cell-to-cell contact. By scanning electron
microscopy the cells appeared to adhere to one another by surface contact; filopodia often acted as connectors,
particularly in leukocyte-erythrocyte interaction. Cellular binding of PG-APS and aggregation were dependent
upon C3 fixation. No aggregation was observed when heat-inactivated serum was used as an opsonin. In
contrast to peptidoglycan, an activator of the alternative complement pathway, the group-specific polysaccha-
ride moiety of PG-APS induced no cellular aggregation. Rosette formation was observed in suspensions when
neutrophils were incubated with erythrocytes coated with C3b-opsonized PG-APS. Cell monolayers bound
serum-opsonized PG-APS, but aggregation was observed only when serum was present in the incubation
medium. Similar results were obtained with C5-deficient serum. No aggregation was observed with heat-
inactivated serum or bovine serum albumin. A heat-labile serum component(s) appears to be required to elicit
leukocyte aggregation. It is suggested that C3 fixed to PG-APS acts as a bridge to link cells together in clusters
as a result of common recognition of C3 by leukocyte and erythrocyte complement receptors.
It is well established that peptidoglycan-polysaccharide
polymers of group A streptococcal cell walls (PG-APS)
produce a recurrent, inflammatory, erosive arthritis in ex-
peritnental animals (2, 41). Many features of the animal
model of arthritis are similar to those of human rheumatoid
arthritis, including reactivation, severe synovitis, pannus
formation, and erosion of cartilage and bone (41). The
peptidoglycan moiety of PG-APS has been reported as the
most active cell wall component for activation of the alter-
native complement pathway both in vitro (16) and in vivo
(20). The alternative complement pathway serves as a pri-
mary recognition mechanism in a nonimmune host for a
variety of microbial components such as peptidoglycan from
staphylococci (46), lipopolysaccharides from gram-negative
bacteria (12), teichoic acid from pneumococci (47), and
zymosan from yeasts (32).
Complement activation results in cleavage of C3 to a
major fragment C3b, which is fixed to the bacterial surface
and serves as an opsonin for phagocytes. Human neutro-
phils, monocytes, and eosinophils express two types of
membrane complement receptors designated CR1 and CR3,
in contrast to erythrocytes, which express only CR1. These
receptors have specificities for different sites on the C3
molecule (5, 10, 38, 39). The CR1 binds to C3b and iC3b,
whereas CR3 binds only to iC3b. Lymphocytes express, in
addition to CR1, another complement receptor designated
CR2, which binds to the C3d or d region of iC3b and C3dg
(10, 22, 38, 39). Specific membrane receptors for C3 present
on neutrophils, monocytes, B-lymphocytes, and erythro-
cytes (5, 6, 9, 22, 37, 38) mediate participation of these cells
in immune adherence (7, 27, 28, 36, 43, 44) and stimulation of
antibody-secreting cells (25, 26, 31).
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To understand the pronounced inflammatory response to
streptococcal components by the host, it is essential to
investigate the early cellular response, especially those cells
involved in antigen clearance. Our previous investigation
has shown that opsonized PG-APS induces capping of CR1
and CR3 on the neutrophil membrane (33), and recently
Leong and Cohen (24) have shown that serum-opsonized
PG-APS inhibits neutrophil killing of Staphylococcus au-
reus. In the present study, sonicates of group A streptococ-
cal cell walls, opsonized with either purified C3 or normal
human serum, were used to investigate the in vitro interac-
tion of bacterial debris with human leukocytes and erythro-
cytes. Aggregation of leukocytes and erythrocytes was ob-
served within 30 min after incubation with serum-opsonized
cell walls. It is suggested that C3b fixed to PG-APS acts as a
bridge to link cells together in clusters as a result of common
recognition by leukocytes and erythrocytes of this comple-
ment component by complement receptors.
Parts of this work were presented at the American Society
for Cell Biology Meetings (E. K. MacRae, K. B.
Pryzwansky, J. D. Lambris, and J. H. Schwab, J. Cell Biol.
95:13a, 1982).
MATERIALS AND METHODS
The physical, chemical, and arthropathic properties of a
100P fraction of purified cell walls derived from group A
streptococci have been described (11). This preparation has
a molecular weight average of 5.0 x 107 and is composed of
peptidoglycan-polysaccharide polymers. The polymers con-
sist only of N-acetylglucosamine, N-acetylmuramic acid, and
rhamnose as sugars and have less than 0.5% non-
peptidoglycan-associated amino acids. N-Acetylmuramic
acid, N-acetylglucosamine, rhamnose, and glucose were
assayed as their alditol acetates by gas-liquid chromatogra-
phy (40). Rhamnose was also assayed by the method of
Dische and Shettles (4). Amino acid analysis was performed
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by using a high pressure liquid chromatography system
adapted to perform post-column derivatization amino acid
analysis (18). This 100P fraction can be sedimented at 100,000
x g for 1 h in a T-865 rotor in a Sorvall OTD-2 ultracentrifuge.
For these studies the pellet was suspended in phosphate-
buffered saline (PBS) to a concentration of 2 mg of rhamnose
per ml. These cell wall fragments are referred to as PG-APS.
Purified group A polysaccharide (APS) and group A
peptidoglycan (PG) were prepared as described previously
from PG-APS (16). PG was sonicated in a Raytheon 9KC
sonic oscillator for 2 min. These cell wall preparations were
opsonized at a concentration of 100 p,g (dry weight) per ml
with 10% human serum for 15 min at 37°C.
PG-APS was incubated with normal human serum as
follows: 4 mg of PG-APS in a total volume of 2 ml of PBS
was incubated for 15 min at 37°C with whole human type AB
serum to achieve a final concentration of 10% serum. The
pellet, referred to as serum-(PG-APS), was washed three
times with cold PBS at 4°C by centrifugation at 100,000 x g
and suspended in PBS to a final concentration of 2 mg of
rhamnose per ml. A control fraction was prepared as de-
scribed above, but incubated in PBS. These washed and
opsonized PG-APS were used for the rosette assay.
In addition, C3b was fixed to PG-APS [C3b-(PG-APS] by
using C3, which was purified from human plasma as de-
scribed in detail elsewhere (21-23). C3 was judged to be
>95% pure by sodium dodecyl sulfate-polyacrylamide gel
electrophoresis and immunodiffusion analysis. Four milli-
grams of PG-APS in a total volume of 2 ml was incubated
with S mg of C3 in the presence of 100 ,ug of trypsin for 2 min
at 37°C. The reaction was stopped by the addition of a
threefold molar excess of soybean trypsin inhibitor (300 ,ug)
and put on ice. The C3b-(PG-APS) was washed three times
by centrifugation at 100,000 x g with cold PBS at 4°C.
C5-deficient serum (100%) was also used as an opsonin.
Serum was immunoabsorbed with agarose coupled to anti-
body specific for C5, and the serum was reconstituted to its
original volume. The specificity of the anti-C5 has been
reported (21).
Preparation of antiserum to group A streptococcus. Anti-
serum to group A streptococcus was raised in rabbits immu-
nized with group A streptococcal vaccine. The antibody
specific for the N-acetylglucosamine epitope of the group A
polysaccharide (APS) was isolated by affinity chromatogra-
phy (8) and conjugated with fluorescein isothiocyanate as
previously described (35).
Preparation of cell monolayers and suspensions. Peripheral
human venous blood was allowed to clot onto 8-mm glass
cover slips as previously described (34). The cells were
layered with Gey balanced salts plus 10% human serum, 10%
heat-inactivated serum (serum heated for 30 min at 56°C),
10% C5-deficient serum, or 1% bovine serum albumin
(BSA). Monolayers consisted of 90% neutrophils, 8 to 10%
monocytes, and 1 to 2% eosinophils as determined by Wright
staining. Approximately 5 to 10 erythrocytes per leukocyte
were present.
Neutrophils for suspension studies were purified by Ficoll-
Hypaque sedimentation of heparinized blood as previously
described (35). Erythrocytes were removed by hypotonic
lysis in distilled water. Isotonicity was restored with sodium
chloride. Cells were suspended in Gey salts in 1% BSA at a
concentration of 4 x 106 cells per ml. Cell viability was
routinely assessed by trypan blue exclusion; in all cases, this
was greater than 95%.
Incubation of cells with cell wall fragments. PG-APS was
sonicated for 5 min in a Raytheon 9KC sonic oscillator to
disperse the particles and opsonized with 10% serum for 15
min. Monolayers of cells were incubated for 30 min with 100
,ug of serum-(PG-APS) per ml in the presence of 10% serum,
10% heat-inactivated serum, 10% C5-deficient serum, or 1%
BSA in Gey balanced salts. Cells were also incubated with
PG-APS that was not preopsonized. In this instance cells
were incubated for 45 min to obtain equal exposure time of
PG-APS to serum factors. The reaction was stopped by
removing the medium and simultaneously fixing and washing
the cells with 1% paraformaldehyde for 30 min (33, 34).
Monolayers were also incubated for 30 min with PG or APS
in the presence of 10% human serum, 10% heat-inactivated
serum, or 1% BSA.
Cells were stained with fluorescein-labeled antibody to
APS for 30 min at 4°C, washed in PBS, mounted, and viewed
with a Leitz Orthoplan Fluorescent Microscope with inci-
dent light excitation with filter pack H and edge filter K480 to
minimize quenching.
SEM. Cells were fixed with 1.5% glutaraldehyde in 0.1 M
phosphate buffer (pH 7.2) and prepared for scanning electron
microscopy (SEM) as previously described (34). The cells
were examined with a JEOL model JSM-35 at 20 kV.
Rosette formation. The aggregation of human erythrocytes
with neutrophils in the presence of opsonized PG-APS was
tested with a rosette assay performed in 10- by 75-mm plastic
tubes. One hundred microliters of erythrocytes (2 x 108/ml)
was mixed with 100 ,ul of preparations (100 ,ug/ml) of
serum-(PG-APS), C3b-(PG-APS), or PG-APS for 30 min at
37°C. The erythrocytes were washed twice with Veronal
buffer (pH 7.2) containing 1% BSA, 3.2% dextrose, and
0.02% NaN3, suspended in 100 ,u1 of Veronal-BSA-dextrose-
NaN3, and mixed with 100 p.1 of neutrophils (4 x 106/ml).
After incubation on a tube rotator for 15 min at 37°C, the
rosettes were counted by phase microscopy.
Quantitation of cell aggregates. An aggregate is defined as
a cluster of four or more cells. One hundred fields were
scanned with a 5OX phase objective, and the number of
aggregates was recorded.
RESULTS
Immunofluorescence. Patches of PG-APS were observed
with fluorescein isothiocyanate-labeled antibody to APS on
the surface of neutrophils and monocytes during the first 5
min of incubation with PG-APS in the presence of serum. As
previously reported (33) the cell walls were localized after 10
min of incubation as a cap on approximately 85% of the
neutrophils. Patching of PG-APS, but not capping, was
observed on monocytes. Aggregates of cells were observed
within 30 min, and cell walls were localized at points of
contact between cells (Fig. 1). Phase microscopy identified
the cells in the clusters as monocytes (usually under the
other cell types), neutrophils, and eosinophils. When eryth-
rocytes were present in the incubation medium, they were
also associated with the aggregate. No binding of PG-APS or
aggregation was detected in the absence of serum or when
PG-APS was opsonized with heat-inactivated serum.
SEM. The surface morphology of the cell-tb-cell interac-
tion was studied by SEM. Aggregates of cells incubated with
PG-APS in the presence of serum consisted of neutrophils,
monocytes, and erythrocytes. The aggregates varied in size
and distribution of cell types. Erythrocytes frequently ap-
peared to rosette around the leukocytes (Fig. 2, 3, and 4).
The shape of the erythrocyte was often distorted, extended,
or stretched. Erythrocytes displayed short processes ex-
tending toward other erythrocytes or leukocytes (Fig. 3).
VOL. 49, 1985




~~~~~~1 ~ ~ ~ .:p
a~~~~~~ ff,w.;,:'
*% *.ed"' "
FIG. 1. Cell aggregation of leukocyte monolayers after 30 min of incubation with PG-APS in the presence of serum. Phase microscopy (A)
reveals the cells as predominately neutrophils. Immunofluorescent staining with fluorescein isothiocyanate-labeled antiserum to APS of the
same field shown by phase microscopy (B) shows localization of PG-APS at the site of cell-cell contact. Note that PG-APS is localized as a
cap on individual neutrophils (arrows).
The number of cells in the aggregates increased with time.
By 30 min some aggregates consisted of 10 or more cells
which included several neutrophils and erythrocytes, one or
two monocytes, and a rare eosinophil. Figure 4 shows an
aggregate consisting of several neutrophils, erythrocytes,
and a monocyte. The monocytes are usually well spread at
the bottom of the aggregate. Contact areas of erythrocytes to
neutrophils in the larger aggregates usually are limited to the
ends of processes, which extend from the irregularly shaped
erythrocyte surface to the neutrophil. In addition, neu-
trophils also extend filopodia to the erythrocyte surface.
Surface distortions of erythrocytes vary from slight indenta-
tions to deep invaginations. No erythrophagocytosis was
observed. Monolayers of cells incubated without cell walls
r~~~~~~~~~~~~~~~~~~~~~I.....I..
FIG. 2. SEM of leukocyte monolayer incubated for 10 min with PG-APS in the presence of serum. Erythrocytes (RBC) are seen in the
process of forming aggregates with neutrophils (PMN). Several erythrocytes are distorted. 5,200x.
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FIG. 3. SEM of erythrocytes in physical contact with two neu-
trophils after 30 min of incubation with PG-APS in the presence of
serum. One erythrocyte has several short processes (short arrow)
extending to a neutrophil; at its other end, one longer filament
extends (long arrow) to a different neutrophil. 7,000x.
or with PG-APS opsonized with heat-inactivated serum did
not form aggregates.
Aggregate formation with streptococcal cell wall compo-
nents. When monolayers of cells were incubated in the
presence of serum with 300 ,ug of purified PG, PG-APS, or
crude cell walls per ml, more than 50 aggregates consisting of
four or more cells were observed in 100 fields with a 5OX
objective (data not shown). No aggregates were observed
with cells incubated with APS.
Aggregate formation with serum-opsonized PG-APS. To
understand the serum factors involved in eliciting cell aggre-
gation, serum-(PG-APS) (preopsonized) or PG-APS (not
preopsonized) were incubated with monolayers of cells in
the presence of fresh serum, heat-inactivated serum, C5-
deficient serum, or BSA. Immunofluorescence microscopy
TABLE 1. Serum factors required for PG-APS induced leukocyte
aggregation and leukocyte binding of PG-APSa
Serum-(PG-APS) PG-APS
Incubation medium Aggregationb Bindingc Aggregation Binding
Normal serum + + + +
Heat-inactivated serum - +
C5-deficient serum + + + +
BSA - + - -
a Monolayers of leukocytes were incubated with serum-opsonized or
nonopsonized PG-APS for 30 or 45 min, respectively, with different serum
factors.
b +, >40 aggregates consisting of four or more leukocytes observed in 100
fields with a 5OX objective.
c +, >85% binding. Immunofluorescence microscopy with antibody to APS
was used to determine binding of PG-APS to leukocytes.
FIG. 4. SEM of an aggregate after 30 min of incubation of
PG-APS in the presence of serum. The cluster consists of four
erythrocytes, at least four neutrophils, and an underlying well
spread monocyte (white arrow). Processes from the neutrophil
extending toward an erythrocyte are seen in the area of the black
arrow. 5,000x.
confirmed that complement activation was required for
binding of PG-APS to neutrophils (Table 1). No binding of
PG-APS to cells was observed with heat-inactivated serum
or BSA.
Binding of PG-APS to leukocytes was insufficient to
induce cell aggregation (Table 1). Although cells bound
serum-(PG-APS), aggregation was not observed when cells
were incubated with heat-inactivated serum or BSA, but
aggregation was observed in normal serum or CS-deficient
serum.
Rosette formation. We have previously shown that PG-
APS binds to neutrophils by CR1 and CR3 and that binding
of C3b-(PG-APS) can be blocked with neutrophils preincu-
bated with anti-CR1 or fluid-phase C3b (33). Aggregation of
human erythrocytes with neutrophils was tested by using
C3b-(PG-APS) with a rosette assay. Rosette formation was
positive for suspensions of neutrophils incubated with hu-
man erythrocytes coated with purified C3b-(PG-APS) (95%
rosettes) or serum-(PG-APS) (75% rosettes). No rosettes
were observed with heat-inactivated serum or PG-APS
alone.
DISCUSSION
We have previously shown that binding of group A strep-
tococcal cell walls to human neutrophils depends upon
complement activation, fixation of C3 to the cell walls, and
recognition of opsonized cell wall fragments by neutrophil
CR1 and CR3 receptors (33). The present experimental data
show that serum-opsonized PG-APS fragments induce ag-
gregation of cells that are known to have C3 receptors,
namely, neutrophils, eosinophils, monocytes, and erythro-
cytes. The cell walls are localized at the site of cell-to-cell
VOL. 49, 1985






FIG. 5. Hypothetical model of blood cell interaction of leukocyte monolayers and erythrocytes before and after incubation with PG-APS.
(A) Neutrophils (PMN), monocytes (MN), eosinophils (EOS), and erythrocytes (RBC), are represented with surface membrane receptors for
C3b (CR1) or iC3b (CR3). (B) PG-APS is represented after opsonization with serum. PG-APS activates complement, and a product of C3
cleavage, C3b, is fixed on multiple sites on the PG-APS fragments. Action of serum factors I and H on the fixed C3b generates iC3b. (C) An
aggregate is represented of neutrophils, erythrocytes, eosinophils, and monocytes after incubation with serum-opsonized PG-APS. It is
hypothesized that C3b-(PG-APS) or iC3b-(PG-APS) cross-links cells with receptors for C3b and iC3b.
contact, and erythrocytes, if present, form rosettes with
leukocytes. Erythrocyte rosetting with neutrophils is depen-
dent upon coating erythrocytes with PG-APS opsonized with
whole serum or purified C3. The rosetting assay provides
evidence that C3b fixed to PG-APS binds to erythrocyte C3b
receptors, and rosetting of erythrocytes to neutrophils is
achieved by neutrophil recognition of excess molecules of
C3b fixed to the PG-APS-coated erythrocytes.
Aggregation of leukocyte monolayers by PG-APS is de-
pendent upon soluble factors generated during complement
activation. Although monolayers bind PG-APS opsonized
with serum, aggregation occurs only when serum is present
in the incubation medium. Because C5-deficient serum also
induces aggregation, it appears that chemotactic factor C5a
is not essential. No cell aggregation is observed with heat-
inactivated serum or BSA. Thus, it appears that activation of
a heat-labile serum factor(s) is important to stimulate cell
aggregation.
With cell suspensions, purified C3b is sufficient for rosette
formation, and serum in the incubation medium is not
required. Differences in these observations lie in the assay.
The rosette assay requires repeated cell contact, which is
achieved by rotating cell suspensions in a small volume of
liquid. In contrast, cell contact is minimal during random
motility of leukocyte monolayers. The data suggest that
aggregation of cell monolayers exposed to PG-APS is elic-
ited by C3 fixation to the cell walls and heat-labile serum
factor(s). Since no aggregation is observed in cell suspen-
sions, adherence also seems to be required. A model sug-
gesting a mechanism for aggregate formation of leukocytes
and erythrocytes induced by C3 opsonized PG-APS is shown
in Fig. 5.
Because monolayers of leukocytes can be stimulated to
cluster after response to chemotactic stimuli, e.g., migration
toward necrotic cells or bacteria, we hypothesized that
chemotactic factor C5a might be involved in the aggregation
response. Therefore, C5-deficient serum was used in the
assay to test this hypothesis. We were surprised to find that
C5-deficient serum elicited results similar to those of normal
serum. Experiments are in progress to determine the re-
quired serum factors.
PG is the moiety of the cell wall polymer required for cell
aggregation. No aggregates are formed with group-specific
carbohydrate APS. It has prevously been shown that PG of
group A streptococcal cell walls is the most active compo-
nent for activating the alternative complement pathway, and
that APS does not activate complement (16). The normal
serum used in these studies apparently has insufficient
antibody to APS to activate the classical pathway and cause
C3b fixation to the cell walls.
Aggregate composition and surface morphology were de-
termined by phase microscopy and SEM. The monocyte,
which has a greater surface area during adhesion than the
neutrophil, is generally found at the bottom of the aggregate,
with the other cell types located on top of or at the periphery
of the monocyte. Filopodia, present on both neutrophils and
monocytes, often appear to act as connectors between cells.
This connection is particularly evident between leukocytes
and erythrocytes. The erythrocytes, which form rosettes
with leukocytes, often appear distorted, since they are
pulled by adjacent leukocytes. With microcinematography
we have observed neutrophils carrying erythrocytes during
locomotion; aggregation appears to be transient, because
cells begin to detach from the aggregate after 1 h of incuba-
tion. No erythrophagocytosis is observed.
Both clinical and experimental studies have shown that C3
plays an important role in host defense (7, 26, 27, 29). For
example, in experimental animals complement appears to
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influence the course of disease. PG-APS produces a recur-
rent, inflammatory erosive arthritis in rats (2, 41). The
severity of the acute joint inflammation correlates with
serum complement levels in complement-depleted rats in-
jected with PG-APS (42). Similarly, granulocytopenia is one
of the earliest responses after intravenous injection of pneu-
mococcal cell walls in rabbits (13), and pneumococcal chal-
lenge of complement-depleted rabbits produces a signifi-
cantly smaller reduction in circulating granulocytes and lack
of pulmonary leukostasis (14).
Dierich and Landen (3) provide evidence that C3 and C5
can initiate the formation of bridges between leukocytes and
erythrocytes that have been preincubated with complement
components. They suggest that enzymes on one cell liberate
labile binding groups of complement components on adja-
cent cells, thus inducing coupling of the two cells. C3b was
unable to serve the same response, suggesting that cell
interaction elicited by C3b-(PG-APS) is different.
Recently C3 has been shown to play a role in the formation
of cell aggregates of concanavalin A-stimulated murine
spleen cells (17). In the presence of autologous serum, C3 is
deposited on the surface of T blast cells, which is followed
by aggregation of cells expressing complement receptors.
Based on the data presented in this paper, aggregation of
cells by opsonized streptococcal cell walls represents an-
other mechanism of cell bridging which may play a role in
cell-cell interaction.
Numerous immunological phenomena are based upon
cell-cell interactions involving immune adherence mediated
by humoral factors (29). Some examples include induction of
an antibody response by B cells (45), sensitization ofT cells
(15), macrophage-lymphocyte effects on target cells (30), and
granulocyte-endothelium interactions (19). It can be hypoth-
esized that binding of cell walls to leukocytes and erythro-
cytes with subsequent cell-to-cell interaction in vitro could
also occur in vivo. It has recently been observed that
immune complexes administered intraarterially to primates
adhere to erythrocytes and are removed in the liver by
Kupffer cells (1). Since 85% of the C3b receptors in periph-
eral blood are found on erythrocytes (10) and they bind
PG-APS, it is likely that they play an important role in
clearance of bacterial debris as well. Although the biological
significance of attachment of complexes or cells bearing C3b
to erythrocytes is not clear, it may act as an immobilizing
mechanism important in dealing with pathogenic agents. We
suggest that the immune adherence phenomenon of PG-APS
to cells with C3 receptors may play a role in the transport of
bacterial debris to various tissues and the subsequent pathol-
ogy.
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